Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Oncogenesis
SJR: 0.946 SNIP: 0.503 CiteScore™: 2

ISSN Print: 0893-9675
ISSN Online: 2162-6448

Critical Reviews™ in Oncogenesis

DOI: 10.1615/CritRevOncog.v5.i4.40
pages 389-428

Tissue-Specific Transformation by Oncogenic Mutants of Epidermal Growth Factor Receptor

T. H. Carter
William K. Warren Medical Research Institute, Department of Medicine, University of Oklahoma Health Sciences Center, P. O. Box 26901, Oklahoma City, OK 73190
H. J. Kung
Department of Molecular Biology and Microbiology, Case Western Reserve University, School of Medicine, Cleveland, OH 44106-4960


Mutations in the receptor for the epidermal growth factor provide valuable insight into mechanisms of growth control. Oncogenic mutants of this receptor tyrosine kinase cause erythroid leukemia, fibrosarcoma, angiosarcoma, glioblastoma, and melanoma. Mutations in the avian protooncogene occur by retroviral mechanisms. Deletion of the ligand-binding domain results in erythroblastosis, while additional mutations in cytoplasmic structures broaden the disease potential to other cell types. A carboxyl-terminal structure of erbB oncogenes modulates growth responses in a complex, cell-specific manner; this tissue-specificity region appears to promote growth in erythroblasts and to produce trans-dominant inhibition in fibroblasts. Human glioblastoma multiforme frequently contains receptor mutations that are reminiscent of avian oncogenes. In hereditary melanoma of Xiphophorus, aberrant regulation of transcription by a recombinant promoter determines tissue-specific tumorigenesis. The diversity of oncogenic mutations raises important questions concerning the roles of several receptor structures. The extracellular domain inhibits the receptor when unoccupied by ligand, for example, through a mechanism that is unknown. The auto-phosphorylation sites are dispensable for transformation, so their function in neoplastic growth is unclear. The carboxyl-terminal region promotes or blocks transformation in different tissues, suggesting complex regulation by unknown cellular factors. These issues are critical to understanding of the mechanisms of receptor activation and tissue tropism for this family of oncogenes.

Articles with similar content:

AML1-ETO—Mediated Erythroid Inhibition: New Paradigms for Differentiation Blockade by a Leukemic Fusion Protein
Critical Reviews™ in Eukaryotic Gene Expression, Vol.15, 2005, issue 3
Kamaleldin E. Elagib, Adam N. Goldfarb, Youngjin Choi
Regulation of Epithelial Cell Proliferation, Differentiation, and Plasticity by Grainyhead-Like 2 During Oral Carcinogenesis
Critical Reviews™ in Oncogenesis, Vol.23, 2018, issue 3-4
Mo K. Kang, Wei Chen, No-Hee Park
IgM-Mediated B Cell Apoptosis
Critical Reviews™ in Immunology, Vol.15, 1995, issue 3-4
Kenji Katamura, Kwang-Myong Kim, Daisuke Hata, Yusei Ohshima, Kenshi Furusho, Mitsufumi Mayumi, Toshio Heike
Steel Factor and c-kit Protooncogene: Genetic Lessons in Signal Transduction
Critical Reviews™ in Oncogenesis, Vol.5, 1994, issue 2-3
Janna M. Blechman, David Givol, Yosef Yarden, Sima Lev
Mechanisms That Contribute to the Development of Lymphoid Malignancies: Roles for Genetic Alterations and Cytokine Production
Critical Reviews™ in Immunology, Vol.16, 1996, issue 1
Kenneth L. Bost, Laura S. Levy